|
PREMPHARM’s Clarus™
(isotretinoin) is now being introduced to Canadian healthcare
professionals.
Clarus therapy includes the CLEAR™
(Clinical Education and Awareness Resource)
program, which assists healthcare professionals and patients with
education and risk management. This program, in addition to our support
of research through the Canadian Dermatology Foundation, reflect
PREMPHARM’s growing investment in the Dermatology community.
|